Pub Date : 2023-03-28eCollection Date: 2023-06-01DOI: 10.1002/wjo2.93
Beatrice C Go, Ariel S Frost, Oren Friedman
Objective: As the population ages, facial plastic providers must remain aware of the treatments to prevent and reverse the external signs of aging. In the mandibular region, skin laxity and soft tissue sagging in the jawline may lead to jowling and chin ptosis along with reduced chin projection. While surgical procedures, including chin implantation, may be performed, nonsurgical procedures are becoming increasingly popular due to their temporary, noninvasive, yet effective methods. This review covers the use of hyaluronic acid, calcium hydroxylapatite, poly-l-lactic acid, and polymethyl methacrylate in the jawline.
Methods: PubMed was searched for data on the mechanism of action, pertinent anatomy, indications, contraindications, technique, and evidence supporting the safety and efficacy of the fillers.
Results: There are a wide variety of fillers available for use in the lower face with unique characteristics and application methods. While the advantages of injectable fillers include relatively affordable cost, minimal patient discomfort, and limited recovery times, taking measures to prevent short- and long-term complications is necessary for optimal results.
Conclusions: Understanding the benefits and limitations of injectable fillers in the jawline can help providers appropriately counsel and treat patients.
{"title":"Using injectable fillers for chin and jawline rejuvenation.","authors":"Beatrice C Go, Ariel S Frost, Oren Friedman","doi":"10.1002/wjo2.93","DOIUrl":"10.1002/wjo2.93","url":null,"abstract":"<p><strong>Objective: </strong>As the population ages, facial plastic providers must remain aware of the treatments to prevent and reverse the external signs of aging. In the mandibular region, skin laxity and soft tissue sagging in the jawline may lead to jowling and chin ptosis along with reduced chin projection. While surgical procedures, including chin implantation, may be performed, nonsurgical procedures are becoming increasingly popular due to their temporary, noninvasive, yet effective methods. This review covers the use of hyaluronic acid, calcium hydroxylapatite, poly-l-lactic acid, and polymethyl methacrylate in the jawline.</p><p><strong>Methods: </strong>PubMed was searched for data on the mechanism of action, pertinent anatomy, indications, contraindications, technique, and evidence supporting the safety and efficacy of the fillers.</p><p><strong>Results: </strong>There are a wide variety of fillers available for use in the lower face with unique characteristics and application methods. While the advantages of injectable fillers include relatively affordable cost, minimal patient discomfort, and limited recovery times, taking measures to prevent short- and long-term complications is necessary for optimal results.</p><p><strong>Conclusions: </strong>Understanding the benefits and limitations of injectable fillers in the jawline can help providers appropriately counsel and treat patients.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"9 2","pages":"131-137"},"PeriodicalIF":0.0,"publicationDate":"2023-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b9/33/WJO2-9-131.PMC10296042.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9707608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
World Journal of Otorhinolaryngology - Head and Neck SurgeryVolume 9, Issue 1 p. 105-105 MEMBER LIST OF THE FIRST EDITORIAL BOARD OF WORLD JOURNAL OF OTORHINOLARYNGOLOGY-HEAD AND NECK SURGERYOpen Access Member List of the First Editorial Board of World Journal of Otorhinolaryngology-Head and Neck Surgery First published: 28 March 2023 https://doi.org/10.1002/wjo2.98AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume9, Issue1March 2023Pages 105-105 RelatedInformation
《世界耳鼻咽喉头颈外科杂志》第9卷第1期第105-105页《世界耳鼻咽喉头颈外科杂志》第一编委会成员名单2023年3月28日https://doi.org/10.1002/wjo2.98AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare全文accessShare全文accessShare请查看我们的使用条款和条件,并勾选下面的复选框共享文章的全文版本。我已经阅读并接受了Wiley在线图书馆使用共享链接的条款和条件,请使用下面的链接与您的朋友和同事分享本文的全文版本。学习更多的知识。复制链接分享链接分享到facebooktwitterlinkedinreddit微信本文没有摘要。第9卷第1期2023年3月页105-105
{"title":"Member List of the Second Editorial Board of World Journal of Otorhinolaryngology‐Head and Neck Surgery","authors":"","doi":"10.1002/wjo2.98","DOIUrl":"https://doi.org/10.1002/wjo2.98","url":null,"abstract":"World Journal of Otorhinolaryngology - Head and Neck SurgeryVolume 9, Issue 1 p. 105-105 MEMBER LIST OF THE FIRST EDITORIAL BOARD OF WORLD JOURNAL OF OTORHINOLARYNGOLOGY-HEAD AND NECK SURGERYOpen Access Member List of the First Editorial Board of World Journal of Otorhinolaryngology-Head and Neck Surgery First published: 28 March 2023 https://doi.org/10.1002/wjo2.98AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume9, Issue1March 2023Pages 105-105 RelatedInformation","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"236 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135289975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Author Guidelines.","authors":"","doi":"10.1002/wjo2.97","DOIUrl":"https://doi.org/10.1002/wjo2.97","url":null,"abstract":"","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"9 1","pages":"97-104"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050960/pdf/WJO2-9-97.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9588145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-29eCollection Date: 2023-06-01DOI: 10.1002/wjo2.88
Richard Heyes, Charles H Adler, Nan Zhang, David G Lott, Stephen F Bansberg
Objectives: This study aims to analyze the impact of age and sex on botulinum neurotoxin (BoNT-A) dosing and outcomes in adductor spasmodic dysphonia (AdSD).
Methods: A database review of all spasmodic dysphonia patients treated with BoNT from 1989 to 2018 at the Mayo Clinic in Arizona was performed. Only patients who had received ≥4 injections of BoNT-A for AdSD were included. Patients were divided into two cohorts to analyze age, with an age of first treatment cutoff of 60 years. Patients were divided into male and female cohorts to analyze sex.
Results: The final analysis included 398 patients. The mean dose of BoNT-A per treatment was significantly higher in the younger cohort (4.4 vs. 3.9 units, p = 0.048). The mean maximal benefit was similar (72% vs. 70%, p = 0.48); however, the mean length of benefit was significantly shorter in younger patients (3.0 vs. 3.6 months, p < 0.01). The mean BoNT-A dose was significantly higher in the female cohort (4.2 vs. 3.6 units, p = 0.02). The mean maximal benefit was similar (69% vs. 75%, p = 0.58), as was the mean length of benefit (3.2 vs. 3.5 months, p = 0.11).
Conclusions: This study suggests that age and sex influence BoNT-A dosing and outcomes in AdSD.
{"title":"Significance of age and sex in botulinum neurotoxin dosing for adductor spasmodic dysphonia.","authors":"Richard Heyes, Charles H Adler, Nan Zhang, David G Lott, Stephen F Bansberg","doi":"10.1002/wjo2.88","DOIUrl":"10.1002/wjo2.88","url":null,"abstract":"<p><strong>Objectives: </strong>This study aims to analyze the impact of age and sex on botulinum neurotoxin (BoNT-A) dosing and outcomes in adductor spasmodic dysphonia (AdSD).</p><p><strong>Methods: </strong>A database review of all spasmodic dysphonia patients treated with BoNT from 1989 to 2018 at the Mayo Clinic in Arizona was performed. Only patients who had received ≥4 injections of BoNT-A for AdSD were included. Patients were divided into two cohorts to analyze age, with an age of first treatment cutoff of 60 years. Patients were divided into male and female cohorts to analyze sex.</p><p><strong>Results: </strong>The final analysis included 398 patients. The mean dose of BoNT-A per treatment was significantly higher in the younger cohort (4.4 vs. 3.9 units, <i>p</i> = 0.048). The mean maximal benefit was similar (72% vs. 70%, <i>p</i> = 0.48); however, the mean length of benefit was significantly shorter in younger patients (3.0 vs. 3.6 months, <i>p</i> < 0.01). The mean BoNT-A dose was significantly higher in the female cohort (4.2 vs. 3.6 units, <i>p</i> = 0.02). The mean maximal benefit was similar (69% vs. 75%, <i>p</i> = 0.58), as was the mean length of benefit (3.2 vs. 3.5 months, <i>p</i> = 0.11).</p><p><strong>Conclusions: </strong>This study suggests that age and sex influence BoNT-A dosing and outcomes in AdSD.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"9 2","pages":"168-173"},"PeriodicalIF":0.0,"publicationDate":"2023-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296044/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9707607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-12eCollection Date: 2023-06-01DOI: 10.1002/wjo2.87
Parhom Towfighi, Alison Hill, Jason R Crossley, Amanda Walsh, James A Leonard, Jonathan P Giurintano, Matthew L Pierce, Michael J Reilly
Objectives: Investigate opioid usage and postoperative pain in patients undergoing head and neck free flap surgery.
Methods: A retrospective review of 100 consecutive patients undergoing head and neck free flap reconstruction at two academic centers was performed. Data captured included demographics, postoperative inpatient pain, pain at postoperative visits, morphine equivalent doses (MEDs) administration, medication history, and comorbidities. Data were analyzed using regression models, χ2 tests, and student's t-tests.
Results: Seventy-three percent of patients were discharged with opioid medication, with over half (53.4%) continuing to take opioids at their second postoperative visit, and over one-third (34.2%) continuing to take them around 4-month postoperatively. One out of every five (20.3%) opioid-naïve patients chronically took opioids postoperatively. There was a poor association between inpatient postoperative pain scores and daily MEDs administered (R2 = 0.13, 0.17, and 0.22 in postoperative Days 3, 5, and 7, respectively). Neither preoperative radiotherapy nor postoperative complications were associated with an increase in opioid usage.
Conclusions: For patients undergoing head and neck free flap operations, opioid medications are commonly used for postoperative analgesia. This practice may increase the chance an opioid-naïve patient uses opioids chronically. We found a poor association between MEDs administered and patient-reported pain scores, which suggests that standardized protocols aimed at optimizing analgesia while reducing opioid administration may be warranted. Level of Evidence: 3 (Retrospective cohort study).
目的:调查头颈部游离皮瓣手术患者阿片类药物的使用情况和术后疼痛:调查头颈部游离皮瓣手术患者阿片类药物的使用情况和术后疼痛:方法:对两家学术中心连续接受头颈部游离皮瓣重建手术的 100 名患者进行回顾性研究。采集的数据包括人口统计学、术后住院疼痛、术后就诊疼痛、吗啡当量剂量(MED)用药、用药史和合并症。数据分析采用回归模型、χ 2 检验和学生 t 检验:73%的患者出院时服用了阿片类药物,超过一半(53.4%)的患者在术后第二次就诊时继续服用阿片类药物,超过三分之一(34.2%)的患者在术后4个月左右继续服用阿片类药物。每五名阿片类药物无效患者中就有一人(20.3%)在术后长期服用阿片类药物。住院患者的术后疼痛评分与每日MEDs用量之间的关系不大(术后第3、5和7天的R 2分别为0.13、0.17和0.22)。术前放疗和术后并发症都与阿片类药物用量的增加无关:结论:对于接受头颈部游离皮瓣手术的患者,阿片类药物通常用于术后镇痛。这种做法可能会增加阿片类药物过敏患者长期使用阿片类药物的几率。我们发现所使用的 MEDs 与患者报告的疼痛评分之间的关系不大,这表明有必要制定标准化方案,在减少阿片类药物用量的同时优化镇痛效果。证据等级:3(回顾性队列研究)。
{"title":"A retrospective analysis of pain and opioid usage in head and neck free flap reconstruction.","authors":"Parhom Towfighi, Alison Hill, Jason R Crossley, Amanda Walsh, James A Leonard, Jonathan P Giurintano, Matthew L Pierce, Michael J Reilly","doi":"10.1002/wjo2.87","DOIUrl":"10.1002/wjo2.87","url":null,"abstract":"<p><strong>Objectives: </strong>Investigate opioid usage and postoperative pain in patients undergoing head and neck free flap surgery.</p><p><strong>Methods: </strong>A retrospective review of 100 consecutive patients undergoing head and neck free flap reconstruction at two academic centers was performed. Data captured included demographics, postoperative inpatient pain, pain at postoperative visits, morphine equivalent doses (MEDs) administration, medication history, and comorbidities. Data were analyzed using regression models, <i>χ</i> <sup>2</sup> tests, and student's <i>t</i>-tests.</p><p><strong>Results: </strong>Seventy-three percent of patients were discharged with opioid medication, with over half (53.4%) continuing to take opioids at their second postoperative visit, and over one-third (34.2%) continuing to take them around 4-month postoperatively. One out of every five (20.3%) opioid-naïve patients chronically took opioids postoperatively. There was a poor association between inpatient postoperative pain scores and daily MEDs administered (<i>R</i> <sup>2</sup> = 0.13, 0.17, and 0.22 in postoperative Days 3, 5, and 7, respectively). Neither preoperative radiotherapy nor postoperative complications were associated with an increase in opioid usage.</p><p><strong>Conclusions: </strong>For patients undergoing head and neck free flap operations, opioid medications are commonly used for postoperative analgesia. This practice may increase the chance an opioid-naïve patient uses opioids chronically. We found a poor association between MEDs administered and patient-reported pain scores, which suggests that standardized protocols aimed at optimizing analgesia while reducing opioid administration may be warranted. <b>Level of Evidence:</b> 3 (Retrospective cohort study).</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"9 2","pages":"153-159"},"PeriodicalIF":0.0,"publicationDate":"2023-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a2/c2/WJO2-9-153.PMC10296052.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9714524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-23eCollection Date: 2023-06-01DOI: 10.1002/wjo2.84
Andrea Ziegler, Monica Patadia, Chirag Patel
Objectives: Resection of the middle turbinate (MT) during endoscopic sinus surgery (ESS) has been a controversial topic among otolaryngologists for many years. Some studies advocate resection and have shown improved outcomes postoperatively, while studies favoring preservation show a decreased incidence of postoperative complications. The current practice pattern regarding this subject is unknown. The goal of this study was to learn the current practice of MT resection during ESS among otolaryngologists.
Method: We performed an electronic anonymous survey of practicing otolaryngologists.
Results: We found that the majority of the 252 responders stated that they will perform an MT resection in certain clinical situations, while there is a small subset that advocates never resecting the MT for inflammatory sinus disease (n = 6, 2.4%). Participants were significantly more likely to perform MT resection in patients undergoing revision compared to primary ESS for all conditions included. The complication of greatest concern among participants was iatrogenic frontal sinus obstruction, while empty nose was of the least concern. The majority of participants responded that MT resection was of extreme or moderate benefit for improved visualization and drug delivery postoperatively. When compared to general otolaryngologists, fellowship-trained rhinologists were less concerned about potential complications following MT resection and were more likely to perceive an extreme or moderate benefit from turbinate resection postoperatively.
Conclusion: There remains debate over MT resection among otolaryngologists, but the results of this study show that the majority of participating otolaryngologists will perform a resection in certain clinical situations.
{"title":"Current practices regarding middle turbinate resection among otolaryngologists.","authors":"Andrea Ziegler, Monica Patadia, Chirag Patel","doi":"10.1002/wjo2.84","DOIUrl":"10.1002/wjo2.84","url":null,"abstract":"<p><strong>Objectives: </strong>Resection of the middle turbinate (MT) during endoscopic sinus surgery (ESS) has been a controversial topic among otolaryngologists for many years. Some studies advocate resection and have shown improved outcomes postoperatively, while studies favoring preservation show a decreased incidence of postoperative complications. The current practice pattern regarding this subject is unknown. The goal of this study was to learn the current practice of MT resection during ESS among otolaryngologists.</p><p><strong>Method: </strong>We performed an electronic anonymous survey of practicing otolaryngologists.</p><p><strong>Results: </strong>We found that the majority of the 252 responders stated that they will perform an MT resection in certain clinical situations, while there is a small subset that advocates never resecting the MT for inflammatory sinus disease (<i>n</i> = 6, 2.4%). Participants were significantly more likely to perform MT resection in patients undergoing revision compared to primary ESS for all conditions included. The complication of greatest concern among participants was iatrogenic frontal sinus obstruction, while empty nose was of the least concern. The majority of participants responded that MT resection was of extreme or moderate benefit for improved visualization and drug delivery postoperatively. When compared to general otolaryngologists, fellowship-trained rhinologists were less concerned about potential complications following MT resection and were more likely to perceive an extreme or moderate benefit from turbinate resection postoperatively.</p><p><strong>Conclusion: </strong>There remains debate over MT resection among otolaryngologists, but the results of this study show that the majority of participating otolaryngologists will perform a resection in certain clinical situations.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"9 2","pages":"183-188"},"PeriodicalIF":0.0,"publicationDate":"2022-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1e/34/WJO2-9-183.PMC10296039.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9735386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-27eCollection Date: 2023-06-01DOI: 10.1002/wjo2.82
Jacob C Harris, Jacob G Eide, Rijul S Kshirsagar, Jason A Brant, James N Palmer, Nithin D Adappa
Background: Carcinosarcomas are rare, aggressive malignancies that can arise in the nasal cavity and paranasal sinuses. There are limited outcome data available. Accordingly, we sought to use the National Cancer Database (NCDB) to characterize patient demographics and outcomes.
Method: A retrospective analysis of the NCDB from 2004 to 2016 for patients with sinonasal carcinosarcoma was conducted.
Results: Thirty patients were included. The patients were predominantly male (n = 20), white (n = 23), and privately insured (n = 15), with an average age of 62.4 years. The nasal cavity was the most common subsite (n = 14), followed by the maxillary sinus (n = 8). Most patient were treated with surgery followed by radiation (n = 23), with the remaining undergoing surgery alone (n = 4), radiation alone (n = 2), or no treatment (n = 1). One-third (n = 10) received adjuvant chemotherapy. The 1- and 5-year overall survival (OS) in the cohort were 79.2% and 43.3%, respectively. Univariate log-rank testing showed OS varied based on intervention (P < 0.029), sex (P < 0.042), and age (P < 0.025), while on multivariate analysis none of these factors independently predicted OS.
Conclusions: We describe the demographics and presenting features of a national cohort of sinonasal carcinosarcoma patients. Future research is needed to identify predictors of overall survival, and to assess the optimal roles for radiation and systemic chemotherapy.
背景:癌肉瘤是一种罕见的侵袭性恶性肿瘤,可发生在鼻腔和副鼻窦。目前可获得的结果数据有限。因此,我们试图利用国家癌症数据库(NCDB)来描述患者的人口统计学特征和预后:方法:我们对2004年至2016年国家癌症数据库中的鼻窦癌肉瘤患者进行了回顾性分析:结果:共纳入30例患者。患者主要为男性(20 人)、白人(23 人)和私人保险患者(15 人),平均年龄为 62.4 岁。鼻腔是最常见的部位(14 人),其次是上颌窦(8 人)。大多数患者在接受手术治疗后再接受放射治疗(23 人),其余患者仅接受手术治疗(4 人)、放射治疗(2 人)或不接受治疗(1 人)。三分之一的患者(10 人)接受了辅助化疗。组群的1年和5年总生存率(OS)分别为79.2%和43.3%。单变量对数秩检验显示,OS 因干预措施而异(P P P 结论:我们描述了全国鼻窦癌肉瘤患者队列的人口统计学特征和表现特征。未来的研究需要确定总生存期的预测因素,并评估放疗和全身化疗的最佳作用。
{"title":"Carcinosarcoma of the nasal cavity and paranasal sinuses: Review of the national cancer database.","authors":"Jacob C Harris, Jacob G Eide, Rijul S Kshirsagar, Jason A Brant, James N Palmer, Nithin D Adappa","doi":"10.1002/wjo2.82","DOIUrl":"10.1002/wjo2.82","url":null,"abstract":"<p><strong>Background: </strong>Carcinosarcomas are rare, aggressive malignancies that can arise in the nasal cavity and paranasal sinuses. There are limited outcome data available. Accordingly, we sought to use the National Cancer Database (NCDB) to characterize patient demographics and outcomes.</p><p><strong>Method: </strong>A retrospective analysis of the NCDB from 2004 to 2016 for patients with sinonasal carcinosarcoma was conducted.</p><p><strong>Results: </strong>Thirty patients were included. The patients were predominantly male (<i>n</i> = 20), white (<i>n</i> = 23), and privately insured (<i>n</i> = 15), with an average age of 62.4 years. The nasal cavity was the most common subsite (<i>n</i> = 14), followed by the maxillary sinus (<i>n</i> = 8). Most patient were treated with surgery followed by radiation (<i>n</i> = 23), with the remaining undergoing surgery alone (<i>n</i> = 4), radiation alone (<i>n</i> = 2), or no treatment (<i>n</i> = 1). One-third (<i>n</i> = 10) received adjuvant chemotherapy. The 1- and 5-year overall survival (OS) in the cohort were 79.2% and 43.3%, respectively. Univariate log-rank testing showed OS varied based on intervention (<i>P</i> < 0.029), sex (<i>P</i> < 0.042), and age (<i>P</i> < 0.025), while on multivariate analysis none of these factors independently predicted OS.</p><p><strong>Conclusions: </strong>We describe the demographics and presenting features of a national cohort of sinonasal carcinosarcoma patients. Future research is needed to identify predictors of overall survival, and to assess the optimal roles for radiation and systemic chemotherapy.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"9 2","pages":"115-122"},"PeriodicalIF":0.0,"publicationDate":"2022-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/43/3f/WJO2-9-115.PMC10296035.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9714527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-19eCollection Date: 2023-06-01DOI: 10.1002/wjo2.83
Bin Zhang, Bikash Rai, Kuang-Yu Fei, Zong-Hui Han, Michelle Savu
Objective: Transoral scarless thyroid surgery has proven to be a popular alternative to traditional approaches. Transoral robotic thyroidectomy (TORT) has been reported using ports on the lower lip and axilla. Avoiding axillary incision can further reduce scars on the armpit. Here, we present our preliminary data from the initial 20 consecutive patients to explore the feasibility of three-port TORT without axillary incision.
Methods: From September 2017 to June 2019, we performed TORT at Beijing United Family Hospital using three intraoral ports without axillary incision via the da Vinci Si system with three robotic arms. The outcomes of the procedure were retrospectively reviewed.
Results: Among 20 patients (mean age 30 ± 7 years; mean tumor size 1.64 ± 0.96 cm), 16 patients underwent unilateral thyroid lobectomy and four had total thyroidectomy with or without central neck dissection. Eighteen patients had papillary thyroid carcinomas (PTC), one had a follicular thyroid carcinoma, and one had a thyroid adenoma. The mean surgical time was 221 ± 68 min. The mean number of retrieved central lymph nodes in the PTC patients was 5.6 ± 5. There was no permanent vocal cord palsy or hypocalcemia postoperatively. One patient had transient vocal cord palsy, which resolved within 1 week. Paresthesia of the lower lip and the chin was observed in nine patients, and one patient had a first-degree burn of the skin flap due to the lens.
Conclusion: Three-port TORT without axillary incision is feasible for selected patients and would be a potential alternative for remote-access thyroid surgery to avoid leaving scars on the neck or the armpit.
{"title":"Three-port transoral robotic thyroidectomy without axillary incision: A preliminary report of 20 cases in China.","authors":"Bin Zhang, Bikash Rai, Kuang-Yu Fei, Zong-Hui Han, Michelle Savu","doi":"10.1002/wjo2.83","DOIUrl":"10.1002/wjo2.83","url":null,"abstract":"<p><strong>Objective: </strong>Transoral scarless thyroid surgery has proven to be a popular alternative to traditional approaches. Transoral robotic thyroidectomy (TORT) has been reported using ports on the lower lip and axilla. Avoiding axillary incision can further reduce scars on the armpit. Here, we present our preliminary data from the initial 20 consecutive patients to explore the feasibility of three-port TORT without axillary incision.</p><p><strong>Methods: </strong>From September 2017 to June 2019, we performed TORT at Beijing United Family Hospital using three intraoral ports without axillary incision via the da Vinci Si system with three robotic arms. The outcomes of the procedure were retrospectively reviewed.</p><p><strong>Results: </strong>Among 20 patients (mean age 30 ± 7 years; mean tumor size 1.64 ± 0.96 cm), 16 patients underwent unilateral thyroid lobectomy and four had total thyroidectomy with or without central neck dissection. Eighteen patients had papillary thyroid carcinomas (PTC), one had a follicular thyroid carcinoma, and one had a thyroid adenoma. The mean surgical time was 221 ± 68 min. The mean number of retrieved central lymph nodes in the PTC patients was 5.6 ± 5. There was no permanent vocal cord palsy or hypocalcemia postoperatively. One patient had transient vocal cord palsy, which resolved within 1 week. Paresthesia of the lower lip and the chin was observed in nine patients, and one patient had a first-degree burn of the skin flap due to the lens.</p><p><strong>Conclusion: </strong>Three-port TORT without axillary incision is feasible for selected patients and would be a potential alternative for remote-access thyroid surgery to avoid leaving scars on the neck or the armpit.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"9 2","pages":"138-143"},"PeriodicalIF":0.0,"publicationDate":"2022-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b7/cc/WJO2-9-138.PMC10296045.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10112934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-13eCollection Date: 2023-06-01DOI: 10.1002/wjo2.81
Ariel Lee, Mehdi Abouzari, Meleeka Akbarpour, Adwight Risbud, Harrison W Lin, Hamid R Djalilian
Objective: Tinnitus is defined as the perception of sound in the absence of an external source. We propose the hypothesis that migraine can cause exacerbation of tinnitus in some patients.
Methods: English literature from PubMed has been reviewed.
Results: Studies have reported a high prevalence of cochlear symptoms in patients with migraine headaches and up to 45% of tinnitus patients have been shown to concomitantly suffer from migraine. Both conditions are thought to stem from central nervous system disturbances, involving disruption of the auditory and trigeminal nerve pathways. One proposed mechanism of this association is the modulation of sound sensitivity by trigeminal nerve activation of the auditory cortex during migraine attacks, resulting in tinnitus fluctuation in some patients. Increased brain and inner ear vascular permeability resulting from trigeminal nerve inflammation, can also cause observed headache and auditory symptoms. Tinnitus and migraine also share a number of symptom triggers including stress, sleep disturbances, and dietary factors. These shared features may help explain promising results of migraine therapies for the treatment of tinnitus.
Conclusion: Given the complex association between tinnitus and migraine, further investigation is needed to identify the underlying mechanisms and determine the optimal treatment strategies for managing migraine-related tinnitus patients.
{"title":"A proposed association between subjective nonpulsatile tinnitus and migraine.","authors":"Ariel Lee, Mehdi Abouzari, Meleeka Akbarpour, Adwight Risbud, Harrison W Lin, Hamid R Djalilian","doi":"10.1002/wjo2.81","DOIUrl":"10.1002/wjo2.81","url":null,"abstract":"<p><strong>Objective: </strong>Tinnitus is defined as the perception of sound in the absence of an external source. We propose the hypothesis that migraine can cause exacerbation of tinnitus in some patients.</p><p><strong>Methods: </strong>English literature from PubMed has been reviewed.</p><p><strong>Results: </strong>Studies have reported a high prevalence of cochlear symptoms in patients with migraine headaches and up to 45% of tinnitus patients have been shown to concomitantly suffer from migraine. Both conditions are thought to stem from central nervous system disturbances, involving disruption of the auditory and trigeminal nerve pathways. One proposed mechanism of this association is the modulation of sound sensitivity by trigeminal nerve activation of the auditory cortex during migraine attacks, resulting in tinnitus fluctuation in some patients. Increased brain and inner ear vascular permeability resulting from trigeminal nerve inflammation, can also cause observed headache and auditory symptoms. Tinnitus and migraine also share a number of symptom triggers including stress, sleep disturbances, and dietary factors. These shared features may help explain promising results of migraine therapies for the treatment of tinnitus.</p><p><strong>Conclusion: </strong>Given the complex association between tinnitus and migraine, further investigation is needed to identify the underlying mechanisms and determine the optimal treatment strategies for managing migraine-related tinnitus patients.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"9 2","pages":"107-114"},"PeriodicalIF":0.0,"publicationDate":"2022-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f8/e7/WJO2-9-107.PMC10296047.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9707606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-02eCollection Date: 2023-06-01DOI: 10.1002/wjo2.79
Emma De Ravin, Ariel S Frost, Neal R Godse, Amber D Shaffer, Noel Jabbour, Barry M Schaitkin, Jason Newman, Leila J Mady
Objectives: Otolaryngology-specific requirements were piloted to minimize applicant and program burdens. We investigated the impact of introducing and then removing these requirements on Match outcomes.
Methods: 2014-2021 National Resident Matching Program® data were examined. The primary outcome was the impact of Otolaryngology Resident Talent Assessment (ORTA; prematch 2017, postmatch 2019) and Program-Specific Paragraph (PSP; implemented 2016, optional 2018) on applicant numbers and match rates. Secondary survey analysis assessed candidate perceptions of PSP/ORTA.
Results: Applicant numbers declined significantly during PSP/ORTA (18.9%; p = 0.001). With the optional PSP and postmatch ORTA, applicant numbers increased significantly (39.0%; p = 0.002). Examined individually, mandatory PSP was associated with a significant decline in applicants (p = 0.007), whereas postmatch ORTA was associated with significant increases in applicants (p = 0.010). ORTA and PSP negatively impacted the decision to apply to otolaryngology in 59.8% and 51.3% of applicants, respectively. Conversely, match rate success improved significantly from 74.8% to 91.2% during PSP/ORTA (p = 0.014), followed by a significant decline to 73.1% after PSP was made optional and ORTA moved to postmatch (p = 0.002).
Conclusions: ORTA and PSP correlated with decreased applicant numbers and increased match rate success. As programs seek ways to remove barriers to applying to otolaryngology, the potential consequences of an increasing pool of unmatched candidates must also be considered.
{"title":"Changes in otolaryngology application requirements and match outcomes: Are we doing any better?","authors":"Emma De Ravin, Ariel S Frost, Neal R Godse, Amber D Shaffer, Noel Jabbour, Barry M Schaitkin, Jason Newman, Leila J Mady","doi":"10.1002/wjo2.79","DOIUrl":"10.1002/wjo2.79","url":null,"abstract":"<p><strong>Objectives: </strong>Otolaryngology-specific requirements were piloted to minimize applicant and program burdens. We investigated the impact of introducing and then removing these requirements on Match outcomes.</p><p><strong>Methods: </strong>2014-2021 National Resident Matching Program® data were examined. The primary outcome was the impact of Otolaryngology Resident Talent Assessment (ORTA; prematch 2017, postmatch 2019) and Program-Specific Paragraph (PSP; implemented 2016, optional 2018) on applicant numbers and match rates. Secondary survey analysis assessed candidate perceptions of PSP/ORTA.</p><p><strong>Results: </strong>Applicant numbers declined significantly during PSP/ORTA (18.9%; <i>p</i> = 0.001). With the optional PSP and postmatch ORTA, applicant numbers increased significantly (39.0%; <i>p</i> = 0.002). Examined individually, mandatory PSP was associated with a significant decline in applicants (<i>p</i> = 0.007), whereas postmatch ORTA was associated with significant increases in applicants (<i>p</i> = 0.010). ORTA and PSP negatively impacted the decision to apply to otolaryngology in 59.8% and 51.3% of applicants, respectively. Conversely, match rate success improved significantly from 74.8% to 91.2% during PSP/ORTA (<i>p</i> = 0.014), followed by a significant decline to 73.1% after PSP was made optional and ORTA moved to postmatch (<i>p</i> = 0.002).</p><p><strong>Conclusions: </strong>ORTA and PSP correlated with decreased applicant numbers and increased match rate success. As programs seek ways to remove barriers to applying to otolaryngology, the potential consequences of an increasing pool of unmatched candidates must also be considered.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":"9 2","pages":"144-152"},"PeriodicalIF":0.0,"publicationDate":"2022-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296048/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9714526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}